Quick Read
Verizon (VZ) and Pfizer (PFE) yield over 6%, and together with Kraft Heinz produce a blended 6.59% yield on a $30,000 portfolio.
Reinvesting dividends at the blended yield compounds the portfolio passively, adding roughly $130 in new annual income the following year without timing the market.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Kraft Heinz didn’t make the cut. Grab the names FREE today.
Passive income arrives while you sleep, commute, or vacation. That appeal drives dividend investing: a paycheck every quarter regardless of market conditions or work hours.
Layoff announcements have rattled white-collar industries through the first half of 2026, and essentials costs climb faster than most household raises. Building a cash-flowing portfolio is one of the few defenses an individual investor controls directly. Unlike rental real estate, a high-yield dividend portfolio is liquid, requires no tenant management, and lets you redirect capital with a single trade.
We screened our 24/7 Wall St. dividend equity research database for stocks that pay massive dividends. A collection of companies can generate over $1,900 a year in passive annual income if you invest $10,000 in each stock at the time of this writing.
Verizon Communications
Verizon (NYSE:VZ) is the largest U.S. wireless carrier and fiber broadband powerhouse following the January 20, 2026 close of the Frontier Communications acquisition, which expanded its fiber footprint to more than 30 million homes and businesses.
The dividend is fueled by predictable subscriber cash flow: FY 2025 operating cash flow of $37.1 billion covered $11.5 billion in common dividends with a 1.75x cushion.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Kraft Heinz didn’t make the cut. Grab the names FREE today.
Telecom is a regulated, capital-heavy industry where mature operators return excess cash through dividends rather than reinvest for hypergrowth. Verizon raised its quarterly payout to $0.7075 per share in 2026, extending annual increases spanning over two decades. Management completed $2.5 billion in buybacks in Q1 2026 while paying down Frontier-related debt.
Pfizer
Pfizer (NYSE:PFE) is a global biopharmaceutical company spanning Primary Care, Specialty Care, and Oncology, with blockbuster brands including Eliquis, Prevnar, Vyndaqel, Ibrance, Padcev, and Nurtec ODT.
